Cargando…
Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
• Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors. • Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma. • Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma. • Only six reported cases, one with compa...
Autores principales: | Paspalj, V., Polterauer, S., Poetsch, N., Reinthaller, A., Grimm, C., Bartl, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253948/ https://www.ncbi.nlm.nih.gov/pubmed/34258357 http://dx.doi.org/10.1016/j.gore.2021.100817 |
Ejemplares similares
-
Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report
por: Lehmann, M., et al.
Publicado: (2023) -
Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report
por: Magdalena, Postl, et al.
Publicado: (2023) -
Clinical analysis of 13 males with primary choriocarcinoma and review of the literature
por: Jiang, Fang, et al.
Publicado: (2014) -
An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
por: Bell, Sarah G., et al.
Publicado: (2021) -
A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab
por: Goldfarb, Jennifer A., et al.
Publicado: (2020)